Remo Eugster

Management Consultant - Life Science - PhD in Pharmaceutical Technology

Basel, Basel, Switzerland

About

With a PhD in Pharmaceutical Sciences and experience in drug development, computational modeling, and industry, I bring a scientific lens to complex business challenges. Passionate about bridging science and strategy to help life sciences organizations drive innovation and create meaningful impact in healthcare.

Experience

  • Management Consultant - Life Sciences at Kearney
    Feb 2026 - Present · 5 mos

    I support life science organizations in navigating complex strategic questions

  • PHD Candidate at University of Bern
    Oct 2022 - Dec 2025 · 3 yrs 3 mos

    The development of lipid-based depot formulations for subcutaneous administration is driven by patient needs. Injectable depot formulations can overcome drawbacks of conventional subcutaneous drug delivery. By local deposition of the delivery system, the immediate systemic exposure can be limited. Further, the frequency of administration can be reduced, due to the sustained release properties of the lipid-based formulation. Developing drug delivery systems for sustained release provides me with the opportunity to help solving complex health problems in a patient centric manner.

  • Novel Solutions & Technologies at Novartis
    Oct 2021 - Sep 2022 · 1 yr

    Development of delivery systems for gene therapies

  • Consultant and Team leader at WEMS Consulting, Trading & Service GmbH
    Feb 2021 - Jun 2021 · 5 mos

    Consulted on regional COVID-19 testing strategies and site layouts across Austria. Led and coordinated a team responsible for administering antigen tests and collecting PCR samples from both patients and the general public during the SARS-CoV-2 pandemic.

  • Novartis (1 yr 2 mos)
    • Device Development
      Apr 2020 - Nov 2020 · 8 mos

      Device Development and Commercialization in Analytics and Testing

    • Device Development Intern (Part time)
      Oct 2019 - Apr 2020 · 7 mos

      Part time Internship in the Analytics and Test Group, Device Development and Commercialization